Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 13.89% is 47% below its 5-year average of 26.46%, near the low end of its 5-year range (5.81%–226.73%).
As of the fiscal period ended Tuesday, June 30, 2026. 16.36% below its 12-month average of 16.61%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
13.89%
NET PROFIT MARGIN AVG TTM
16.61%
NET PROFIT MARGIN AVG 3Y
24.27%
NET PROFIT MARGIN AVG 5Y
26.46%
NET PROFIT MARGIN AVG 10Y
24.99%
NET PROFIT MARGIN AVG 15Y
21.63%
NET PROFIT MARGIN AVG 20Y
19.17%
CURRENT VS TTM AVG
-16.36%
CURRENT VS 3Y AVG
-42.76%
CURRENT VS 5Y AVG
-47.48%
CURRENT VS 10Y AVG
-44.40%
CURRENT VS 15Y AVG
-35.76%
CURRENT VS 20Y AVG
-27.51%
SECTOR MEDIAN · HEALTHCARE
8.68%
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
+60.07%
vs the sector median at left
Edwards Lifesciences Corporation
Market Cap
$53.30B
Net Profit Margin
13.89%
TTM Avg
16.61%
3Y Avg
24.27%
5Y Avg
26.46%
Market Cap
$54.16B
Net Profit Margin
0.62%
TTM Avg
0.63%
3Y Avg
0.57%
5Y Avg
0.27%
Market Cap
$50.14B
Net Profit Margin
4.52%
TTM Avg
8.06%
3Y Avg
8.30%
5Y Avg
8.27%
Market Cap
$44.72B
Net Profit Margin
25.03%
TTM Avg
23.70%
3Y Avg
22.66%
5Y Avg
22.55%
Market Cap
$42.18B
Net Profit Margin
19.55%
TTM Avg
19.27%
3Y Avg
18.75%
5Y Avg
17.94%
Market Cap
$39.75B
Net Profit Margin
8.10%
TTM Avg
8.63%
3Y Avg
8.47%
5Y Avg
7.22%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edwards Lifesciences Corporation (EW) | $53.30B | 13.89% | 16.61% | 24.27% | 26.46% |
| Cardinal Health, Inc. (CAH)vs › | $54.16B | 0.62% | 0.63% | 0.57% | 0.27% |
| Becton, Dickinson and Company (BDX)vs › | $50.14B | 4.52% | 8.06% | 8.30% | 8.27% |
| Cencora, Inc. (COR)vs › | $60.32B | 0.79% | 0.49% | 0.59% | 0.22% |
| Humana Inc. (HUM)vs › | $46.23B | 0.88% | 0.97% | 1.82% | 2.53% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.72B | 25.03% | 23.70% | 22.66% | 22.55% |
| Agilent Technologies, Inc. (A)vs › | $42.18B | 19.55% | 19.27% | 18.75% | 17.94% |
| IQVIA Holdings Inc. (IQV)vs › | $39.75B | 8.10% | 8.63% | 8.47% | 7.22% |
| DexCom, Inc. (DXCM)vs › | $34.52B | 20.12% | 16.12% | 14.73% | 15.57% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $33.33B | 7.86% | 10.12% | 9.68% | 22.03% |
Operating Margin
28.1%
Net Profit Margin
13.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 13.89% |
| 2026-03-31 | 23.09% |
| 2025-12-31 | 5.81% |
| 2025-09-30 | 18.74% |
| 2025-06-30 | 21.52% |
| 2025-03-31 | 25.34% |
| 2024-12-31 | 27.83% |
| 2024-09-30 | 226.73% |
| 2024-06-30 | 26.24% |
| 2024-03-31 | 26.46% |
| 2023-12-31 | 29.21% |
| 2023-09-30 | 30.96% |
| 2023-06-30 | 23.71% |
| 2023-03-31 | 23.33% |
| 2022-12-31 | 29.55% |
| 2022-09-30 | 26.04% |
| 2022-06-30 | 29.58% |
| 2022-03-31 | 27.86% |
| 2021-12-31 | 25.22% |
| 2021-09-30 | 25.96% |
| 2021-06-30 | 35.57% |
| 2021-03-31 | 27.80% |
| 2020-12-31 | 25.97% |
| 2020-09-30 | 28.50% |
| 2020-06-30 | -13.18% |
| 2020-03-31 | 27.52% |
| 2019-12-31 | 23.87% |
| 2019-09-30 | 25.11% |
| 2019-06-30 | 22.29% |
| 2019-03-31 | 25.15% |
| 2018-12-31 | 0.72% |
| 2018-09-30 | 24.92% |
| 2018-06-30 | 29.96% |
| 2018-03-31 | 23.09% |
| 2017-12-31 | 4.02% |
| 2017-09-30 | 20.71% |
| 2017-06-30 | 22.11% |
| 2017-03-31 | 26.06% |
| 2016-12-31 | 20.65% |
| 2016-09-30 | 19.12% |
| 2016-06-30 | 16.67% |
| 2016-03-31 | 20.51% |
| 2015-12-31 | 20.97% |
| 2015-09-30 | 19.19% |
| 2015-06-30 | 18.27% |
| 2015-03-31 | 20.90% |
| 2014-12-31 | 17.67% |
| 2014-09-30 | 15.57% |
| 2014-06-30 | 95.11% |
| 2014-03-31 | 11.54% |
| 2013-12-31 | 14.14% |
| 2013-09-30 | 15.50% |
| 2013-06-30 | 18.04% |
| 2013-03-31 | 28.97% |
| 2012-12-31 | 17.85% |
| 2012-09-30 | 15.45% |
| 2012-06-30 | 14.07% |
| 2012-03-31 | 14.18% |
| 2011-12-31 | 14.67% |
| 2011-09-30 | 12.50% |
| 2011-06-30 | 13.47% |
| 2011-03-31 | 15.80% |
| 2010-12-31 | 16.51% |
| 2010-09-30 | 13.76% |
| 2010-06-30 | 15.74% |
| 2010-03-31 | 14.01% |
| 2009-12-31 | 13.73% |
| 2009-09-30 | 22.57% |
| 2009-06-30 | 14.16% |
| 2009-03-31 | 19.30% |
| 2008-12-31 | 12.30% |
| 2008-09-30 | 10.84% |
| 2008-06-30 | 12.12% |
| 2008-03-31 | 6.13% |
| 2007-12-31 | 5.39% |
| 2007-09-30 | 11.13% |
| 2007-06-30 | 12.80% |
| 2007-03-31 | 12.57% |
| 2006-12-31 | 7.79% |
| 2006-09-30 | 11.24% |
| 2006-06-30 | 13.51% |
| 2006-03-31 | 17.90% |
| 2005-12-31 | 15.46% |
| 2005-09-30 | -1.83% |
| 2005-06-30 | 5.38% |
| 2005-03-31 | 12.53% |
| 2004-12-31 | 10.92% |
| 2004-09-30 | 5.52% |
| 2004-06-30 | 10.87% |
| 2004-03-31 | -26.43% |
| 2003-12-31 | 8.43% |
| 2003-09-30 | 11.89% |
| 2003-06-30 | 9.69% |
| 2003-03-31 | 6.82% |
| 2002-12-31 | 10.68% |
| 2002-09-30 | -10.49% |
